Amanote Research
Register
Sign In
666. Phase I Study Results of Pbi-shRNA™ STMN1 Nanoplex via Intratumoral Injection in Advanced Cancer
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)35679-9
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2014
Authors
Unknown
Publisher
Elsevier BV
Related search
Docetaxel and Cisplatin in Patients With Advanced Gastric Cancer: Results of Japanese Phase I/Ii Study
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Phase I Study of Temozolomide in Paediatric Patients With Advanced Cancer
British Journal of Cancer
Cancer Research
Oncology
331. Phase I Study of the “Triad” Autologous (FANG™) Vaccine, Incorporating Bifunctional shRNAfurin and GMCSF Transgene Expression, in Advanced Cancer Patients
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Regorafenib (BAY 73-4506) in Advanced Colorectal Cancer: A Phase I Study
British Journal of Cancer
Cancer Research
Oncology
Intratumoral Injection of BCNU in Ethanol (DTI-015) Results in Enhanced Delivery to Tumor – A Pharmacokinetic Study
Journal of Neuro-Oncology
Cancer Research
Oncology
Neurology
Phase I/Ii Clinical Trial to Assess Safety and Efficacy of Intratumoral and Subcutaneous Injection of HVJ-E in Castration-Resistant Prostate Cancer Patients
Cancer Gene Therapy
Cancer Research
Molecular Medicine
Molecular Biology
Intratumoral Injection of OK-432 for Inoperable Gastric Cancer.
Japanese Journal of Gastroenterological Surgery
Surgery
Gastroenterology
Anti-Tumour Activity of a First-In-Class Agent NUC-1031 in Patients With Advanced Cancer: Results of a Phase I Study
British Journal of Cancer
Cancer Research
Oncology
A Phase I Trial of Intratumoral Administration of Recombinant Oncolytic Adenovirus Overexpressing HSP70 in Advanced Solid Tumor Patients
Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
